The North America In Vitro Fertilization Market was valued at $215.5 Million in 2024 and projected to reach to $361.9 Million by 2029, representing a compound annual growth rate of 10.9%. North America's In Vitro Fertilization market is positioned for sustained expansion through 2029, driven by demographic shifts, delayed childbearing trends, and rising infertility rates.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America's IVF market is valued at $215.5 million in 2024, with a robust 10.9% CAGR projected through 2029, reaching $361.9 million. This growth outpaces many global regions, driven by increasing demand for assisted reproductive technologies.
The region benefits from state-of-the-art medical facilities, cutting-edge reproductive technology, and highly trained fertility specialists. North America's healthcare ecosystem supports rapid adoption of innovative IVF treatments and procedures.
Increasing awareness of fertility treatment options, coupled with growing acceptance of assisted reproductive technologies, has expanded the patient base. Insurance coverage improvements and reduced stigma are driving higher treatment uptake across North America.
North America maintains robust regulatory standards that ensure treatment safety and efficacy. Clear guidelines from health authorities provide confidence to patients and practitioners, supporting market expansion and consumer trust.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | FROZEN NON-DONORS (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.7% from 2024 to 2029 |
| Largest Segment | EQUIPMENT (Product) |
| Market Size Base Year (Billions) | ~USD 0.95 (2024) |
| Revenue Forecast (Billions) | ~USD 1.65 (2029) |
| Segments Covered | Product, Type, Type Of Cycle, Procedure, End User |
5 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| US | USD 328.6 Million |
| Canada | USD 33.2 Million |
| Mexico | USD 18.1 Million |
The In Vitro Fertilization market in North America was valued at $215.5 million in 2024 and is expected to grow to $361.9 million by 2029.
North America's IVF market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.
Key growth drivers in North America include rising infertility rates, delayed childbearing trends, improved insurance coverage, advanced healthcare infrastructure, and technological innovations in reproductive medicine.
North America's IVF market benefits from superior healthcare infrastructure, higher reimbursement rates, stronger regulatory frameworks, and greater patient awareness compared to many other global regions.
Advancements in embryo selection, cryopreservation techniques, genetic screening, and artificial intelligence-driven treatment optimization are enhancing success rates and driving market growth in North America.
In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.
The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.
Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

To know about the assumptions considered for the study, download the pdf brochure
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.
The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

To know about the assumptions considered for the study, Request for Free Sample Report


The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.
The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market
Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report